Cargando…

Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries

BACKGROUND: An important factor hindering the growth of pharmacovigilance (PV) in resource-limited settings is the lack of adequate funds to establish a functional National Pharmacovigilance System. Consequently, the crucial function of monitoring and ensuring the availability of safe medicines in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Isah, Ambrose O., Opadeyi, Abimbola O., Tumwijukye, Henry, Cobelens, Frank, Smith, Diede, Ndomondo-Sigonda, Margareth, Harmark, Linda, Tanui, Paul, Tiemersma, Edine, Mmbaga, Blandina T., Mahlangu, Gugu, Ayinbuomwan, Stephen A., Soulaymani, Rachida, Pandit, Jayesh M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387667/
https://www.ncbi.nlm.nih.gov/pubmed/37529763
http://dx.doi.org/10.1177/20420986231188836
_version_ 1785081934333870080
author Isah, Ambrose O.
Opadeyi, Abimbola O.
Tumwijukye, Henry
Cobelens, Frank
Smith, Diede
Ndomondo-Sigonda, Margareth
Harmark, Linda
Tanui, Paul
Tiemersma, Edine
Mmbaga, Blandina T.
Mahlangu, Gugu
Ayinbuomwan, Stephen A.
Soulaymani, Rachida
Pandit, Jayesh M.
author_facet Isah, Ambrose O.
Opadeyi, Abimbola O.
Tumwijukye, Henry
Cobelens, Frank
Smith, Diede
Ndomondo-Sigonda, Margareth
Harmark, Linda
Tanui, Paul
Tiemersma, Edine
Mmbaga, Blandina T.
Mahlangu, Gugu
Ayinbuomwan, Stephen A.
Soulaymani, Rachida
Pandit, Jayesh M.
author_sort Isah, Ambrose O.
collection PubMed
description BACKGROUND: An important factor hindering the growth of pharmacovigilance (PV) in resource-limited settings is the lack of adequate funds to establish a functional National Pharmacovigilance System. Consequently, the crucial function of monitoring and ensuring the availability of safe medicines in these settings cannot be guaranteed considering the peculiarities of diseases and medicines used. OBJECTIVES: The objective of this paper is to provide an overview as to the availability of potential sources of funds, which could be explored to ensure Medicine Safety and to proffer a potential framework likely to ensure sustainable funding of PV in Africa. METHODS/PROCESSES: The process of developing this framework entailed a review of PV financing in some developed economies, a landscape study of funding of PV in some African countries, an in-depth understanding of the PV system and the organisational structure and nexus between the regulatory agencies and National Pharmacovigilance Centre. Critical points for consideration included the sources of funds, revenue pool, the disbursement of funds, budgeting and expenditure profile and the legal framework. Consultative meetings, webinars and interviews with experts were carried out. RESULTS: The findings showed that most of the PV systems were mainly integrated into the regulatory agencies regarding operational and fiscal governance with few facilities being independent of the regulatory agencies. The main source of funding was from the government with significant donor funding which is ad hoc and non-sustainable. Several potential sources were identified but yet to be exploited. There were no legal provisions for PV financing. A framework likely to ensure sustainable PV financing is suggested to capture all available sources of funding, mine the potential sources providing a sizeable pool of revenue to address its activities and enabling legal framework which will engender autonomy. Furthermore, it will address the nexus between the regulatory agencies and the PV outfits, thus enabling appropriate share of resources and blockage of diversions. CONCLUSION: In all, addressing the various elements identified in this study and providing the legal provisions which guarantees some degree of autonomy will provide a sustainable mechanism for PV funding in the resource-limited setting of Africa.
format Online
Article
Text
id pubmed-10387667
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-103876672023-08-01 Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries Isah, Ambrose O. Opadeyi, Abimbola O. Tumwijukye, Henry Cobelens, Frank Smith, Diede Ndomondo-Sigonda, Margareth Harmark, Linda Tanui, Paul Tiemersma, Edine Mmbaga, Blandina T. Mahlangu, Gugu Ayinbuomwan, Stephen A. Soulaymani, Rachida Pandit, Jayesh M. Ther Adv Drug Saf Original Research BACKGROUND: An important factor hindering the growth of pharmacovigilance (PV) in resource-limited settings is the lack of adequate funds to establish a functional National Pharmacovigilance System. Consequently, the crucial function of monitoring and ensuring the availability of safe medicines in these settings cannot be guaranteed considering the peculiarities of diseases and medicines used. OBJECTIVES: The objective of this paper is to provide an overview as to the availability of potential sources of funds, which could be explored to ensure Medicine Safety and to proffer a potential framework likely to ensure sustainable funding of PV in Africa. METHODS/PROCESSES: The process of developing this framework entailed a review of PV financing in some developed economies, a landscape study of funding of PV in some African countries, an in-depth understanding of the PV system and the organisational structure and nexus between the regulatory agencies and National Pharmacovigilance Centre. Critical points for consideration included the sources of funds, revenue pool, the disbursement of funds, budgeting and expenditure profile and the legal framework. Consultative meetings, webinars and interviews with experts were carried out. RESULTS: The findings showed that most of the PV systems were mainly integrated into the regulatory agencies regarding operational and fiscal governance with few facilities being independent of the regulatory agencies. The main source of funding was from the government with significant donor funding which is ad hoc and non-sustainable. Several potential sources were identified but yet to be exploited. There were no legal provisions for PV financing. A framework likely to ensure sustainable PV financing is suggested to capture all available sources of funding, mine the potential sources providing a sizeable pool of revenue to address its activities and enabling legal framework which will engender autonomy. Furthermore, it will address the nexus between the regulatory agencies and the PV outfits, thus enabling appropriate share of resources and blockage of diversions. CONCLUSION: In all, addressing the various elements identified in this study and providing the legal provisions which guarantees some degree of autonomy will provide a sustainable mechanism for PV funding in the resource-limited setting of Africa. SAGE Publications 2023-07-24 /pmc/articles/PMC10387667/ /pubmed/37529763 http://dx.doi.org/10.1177/20420986231188836 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Isah, Ambrose O.
Opadeyi, Abimbola O.
Tumwijukye, Henry
Cobelens, Frank
Smith, Diede
Ndomondo-Sigonda, Margareth
Harmark, Linda
Tanui, Paul
Tiemersma, Edine
Mmbaga, Blandina T.
Mahlangu, Gugu
Ayinbuomwan, Stephen A.
Soulaymani, Rachida
Pandit, Jayesh M.
Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries
title Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries
title_full Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries
title_fullStr Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries
title_full_unstemmed Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries
title_short Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries
title_sort funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited african countries
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387667/
https://www.ncbi.nlm.nih.gov/pubmed/37529763
http://dx.doi.org/10.1177/20420986231188836
work_keys_str_mv AT isahambroseo fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT opadeyiabimbolao fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT tumwijukyehenry fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT cobelensfrank fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT smithdiede fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT ndomondosigondamargareth fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT harmarklinda fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT tanuipaul fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT tiemersmaedine fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT mmbagablandinat fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT mahlangugugu fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT ayinbuomwanstephena fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT soulaymanirachida fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries
AT panditjayeshm fundingandfinancialsustainabilityofpharmacovigilancesuggestedmodelsforfundingpharmacovigilanceinresourcelimitedafricancountries